Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis

We present a case of a rapid clinical recovery in a critically ill kidney transplant recipient with SARS-CoV-2 positivity, Epstein–Barr virus (EBV) reactivation and probable secondary hemophagocytic lymphohistiocytosis (HLH) treated with etoposide-free regimen, based on dexamethasone and a single do...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Derek, Karimi, Sabina, Follows, George, Torpey, Nicholas, Suchanek, Ondrej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213214/
https://www.ncbi.nlm.nih.gov/pubmed/35729310
http://dx.doi.org/10.1007/s13730-022-00711-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213214/
https://www.ncbi.nlm.nih.gov/pubmed/35729310
http://dx.doi.org/10.1007/s13730-022-00711-4

Ejemplares similares